Advertisement

Related Videos

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Opening Session Panel Discussion

Welcome and Introduction to Vi3C

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Advertisement

Advertisement




Oct
09
Today In Oncology
John L Cameron Receives Wangensteen Scientific Forum Award
Mastectomy Linked to Worsened Sexual Health and Body Image After Surgery, Study Finds
Patients Value Communication Skills From Cancer Surgeons Across Six Key Areas
Considerations on Cancer Drug Development
Inflammatory Activity and Cancer-Related Fatigue in Early Breast Cancer
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo